Long-term efficacy analysis of radiotherapy and local management of metastases in patients with newly diagnosed oligometastatic nasopharyngeal carcinoma: A prospective, single-arm, single-center clinical study
Nasopharyngeal carcinoma (NPC) is highly sensitive to radiotherapy, and the 5-year survival rate commonly exceeds 80 % after radio-chemotherapy[1]. Distant metastases are always the main challenges, wherein 4–10 % NPC patients experience synchronous distant metastasis at first diagnosis, which lacks standard treatment[2]. However, metastatic NPC is a highly heterogenous disease with different clinical behav iors, and newly diagnosed metastatic NPC (m-NPC) is completely different from post-treatment m-NPC given the discussion on the value of local regional radiotherapy (LRRT) after palliative chemotherapy.
Source: Radiotherapy and Oncology - Category: Radiology Authors: Huang Shuang, Jiang Feng, Cao Caineng, Jin Qifeng, Jin Ting, Hua Yonghong, Chen Xiaozhong Tags: Original Article Source Type: research
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Nasopharyngeal Cancer | Palliative | Radiology | Study